Cocaine and alcohol: A risky association;Cocaine et alcool : des liaisons dangereuses

Presse Medicale

Volumn 39, Issue 3, 2010, Pages 291-302

  Lacoste, Jérôme ^a   Pedrera Melgire, Manuela ^a   Charles Nicolas, Aimé ^a   Ballon, Nicolas ^a  

^a CHU de Fort de France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMANTADINE; ARIPIPRAZOLE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; COCAINE; DISULFIRAM; MODAFINIL; NALTREXONE; PLACEBO; PSYCHOTROPIC AGENT; TIAGABINE; TOPIRAMATE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY; BEHAVIOR THERAPY; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; HUMAN; INTERVIEW; MONOTHERAPY; PSYCHOTHERAPY; RELAPSE; RISK ASSESSMENT; SHORT SURVEY; WITHDRAWAL SYNDROME; COGNITION; PSYCHOLOGICAL ASPECT; REVIEW;

ALCOHOLISM; COCAINE-RELATED DISORDERS; COGNITION; HUMANS;

EID: 77949774802     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.05.011     Document Type: Short Survey

References (80)

1. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990, 264:2511-2518.
2. Carroll K.M., Rounsaville B.J., Bryant K.J. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol 1993, 54:199-208.
3. Brady K.T., Sonne S., Randall C.L., Adinoff B., Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend 1995, 39:69-71.
4. Rasch R.F.R., Weisen C.A., McDonald B., Wechsberg W.M., Perritt R., Dennis M.L. Patterns of HIV risk and alcohol use among African-American crack abusers. Drug Alcohol Depend 2000, 58:259-266.
5. Karch S.B. The history of cocaine toxicity. Hum Pathol 1989, 20:1037-1039.
6. SAMHSA, Office of applied studies. Results from the 2006 National survey on drug use & health: detailed tables. Rockville: Substance abuse and mental health services administration; 2007.
7. OEDT, Observatoire européen des drogues et toxicomanies. Rapport annuel 2007: Etat du phénomène de la drogue en Europe. Luxembourg: Office des publications officielles des Communautés européennes ; 2007.
8. Beck F, Legleye S, Spilka S, Briffault X, Gautier A, Lamboy B et al. Les niveaux d'usage des drogues en France en 2005. Tendances 48. OFDT; 2006. 6 p.
9. Merle S, Rhinan S, Vaissade L. Estimation locale de la prévalence de l'usage problématique de drogues: l'enquête NEMO Martinique. OSM Flash 40. OSM; 2007.
10. Charles-Nicolas A., Lacoste J. Cocaïne, psychostimulants et autres produits. HAS: Abus, dépendances et polyconsommations: stratégies de soins (Paris, 1-2 février 2007). Alcoologie et Addictologie 2007, 29:404-412.
11. Barrett S.P., Darredeau C., Pihl R.O. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol Clin Exp 2006, 21:255-263.
12. Washton A.M., Gold M.S. Recent trends in cocaine abuse: a view from the national hotline " 800-COCAINE" Adv Alcohol Subst Abuse 1986, 6:31-47.
13. Grant B.F., Harford T.C. Concurrent and simultaneous use of alcohol with cocaine: results of a national survey. Drug Alcohol Depend 1990, 25:97-104.
14. Rounsaville B.J., Anton S.F., Carroll K., Budde D., Prusoff B.A., Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991, 48:43-51.
15. Miller N.S., Gold M.S., Belkin B.M., Klahr A.L. The diagnosis of alcohol and cannabis dependence in cocaine dependents and alcohol dependence in their families. Br J Addict 1989, 84:1491-1498.
16. Lacoste J., Charles-Nicolas A. Approche thérapeutique actuelle de la cocaïnomanie. Courrier des Addictions 2006, 8:67-69.
17. Jatlow P., Elsworth J.D., Bradberry C.W., Winger G., Taylor J.R., Russell R., et al. Cocaethylene: A neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci 1991, 48:1787-1794.
18. Katz J.L., Terry P., Witkin J.M. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sci 1992, 50:1351-1361.
19. McCance E.F., Price L.H., Kosten T.R., Jatlow P.M. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 1995, 274:215-223.
20. Bourland J.A., Martin D.K., Mayersohn M. In vitro transesterification of cocaéthylène (ethylcocaine) in the presence of ethanol. Drug Metab Disp 1998, 26:203-206.
21. Hearn W.L., Flynn D.D., Hime G.W., Rose S., Cofino J.C., Mantero-Atienza E., et al. Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 1991, 56:698-701.
22. Farré M., de la Torre R., Gonzalez M.L., Teran M.T., Roset P.N., Menoyo E., et al. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 1997, 283:164-176.
23. Harris D.S., Everhart E.T., Mendelson J., Jones R.T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 2003, 72:169-182.
24. McCance-Katz E.F., Kosten T.R., Jatlow P.M. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone: a multiple-dose study. Biol Psychiatry 1998, 44:250-259.
25. Laizure S.C., Parker R.B. Pharmacodynamic evaluation of the cardiovascular effects after the coadministration of cocaine and ethanol. Drug Metab Dispos 2009, 37:310-314.
26. Hart C.L., Jatlow P., Sevarino K.A., McCance-Katz E.F. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl) 2000, 149:153-162.
27. Lepere B., Charbit B. Cardiovascular complications of cocaine use: recent points on cocaethylene toxicity. Ann Med Interne 2002, 153:1S45-11S.
28. Wilson L.D., Jeromin J., Garvey L., Dorbandt A. Cocaine, ethanol, and cocaethylene cardiotoxicity in an animal model of cocaine and alcohol abuse. Acad Emerg Med 2001, 8:211-222.
29. Lambert G., Karila L., Lowenstein W. Neuro-imagerie et cocaïne: une cartographie de la dépendance?. Presse Med 2008, 37:679-688.
30. Roberts S.M., Roth L., Harbison R.D., James R.C. Cocaethylene hepatotoxicity in mice. Biochem Pharmacol 1992, 43:1989-1995.
31. Bradberry C.W., Lee T., Jatlow P. Rapid induction of behavioral and neurochemical tolerance to cocaethylene, a model compound for agonist therapy of cocaine dependence. Psychopharmacology (Berl) 1999, 146:87-92.
32. Noble F., Sanchez M., Lowenstein W. Interest for delivery of cocaethylene in a sustained release emulsion vs saline evaluated on behavioral sensitization in naive and cocaine-sensitized mice. Psychopharmacology (Berl) 2007, 193:415-421.
33. Baker J., Jatlow P., Pade P., Ramakrishnan V., McCance-Katz E.F. Acute cocaine responses following cocaethylene infusion. Am J Drug Alcohol Abuse 2007, 33:619-625.
34. Khalsa H., Paredes A., Anglin M.D. The role of alcohol in cocaine dependence. Recent Dev Alcohol 1992, 10:7-35.
35. Heil S.H., Badger G.J., Higgins S.T. Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol 2001, 62:14-22.
36. Rubio G., Manzanares J., Jiménez M., Rodríguez-Jiménez R., Martínez I., Iribarren M.M., et al. Use of cocaine by heavy drinkers increases vulnerability to developing alcohol dependence: a 4-year follow-up study. J Clin Psychiatry 2008, 9:563-570.
37. Gossop M., Manning V., Ridge G. Concurrent use and order of use of cocaine and alcohol: behavioural differences between users of crack cocaine and cocaine powder. Addiction 2006, 101:1292-1298.
38. Pennings E.J.M., Leccese A.P., de Wolff F.A. Effects of concurrent use of alcohol and cocaine. Addiction 2001, 97:773-783.
39. Magura S., Rosenblum A. Modulating effects of alcohol use on cocaine use. Addict Behav 2000, 25:117-122.
40. Pakula B., Macdonald S., Stockwell T. Settings and functions related to simultaneous use of alcohol with marijuana or cocaine among clients in treatment for substance abuse. Subst Use Misuse 2009, 44:212-226.
41. Lau-Barraco C., Schmitz J.M. Drug preference in cocaine and alcohol dual-dependent patients. Am J Drug Alcohol Abuse 2008, 34:211-217.
42. Kirby K.C., Lamb R.J., Iguchi M.Y., Husband S.D., Platt J.J. Situations occasioning cocaine use and cocaine abstinence strategies. Addiction 1995, 90:1241-1252.
43. Wallace B.C. Psychological and environmental determinants of relapse in crack cocaine smokers. J Subst Abuse Treat 1989, 6:95-106.
44. Higgins S.T., Roll J.M., Bickel W.K. Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology (Berl) 1996, 123:1-8.
45. Higgins S.T., Rush C.R., Hughes J.R., Bickel W.K., Lynn M., Capeless M.A. Effects of cocaine and alcohol, alone and in combination, on human learning and performance. J Exp Anal Behav 1992, 58:87-105.
46. Robinson J.E., Heaton R.K., O'Malley S.S. Neuropsychologpsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc 1999, 5:10-19.
47. Bolla K.I., Funderburk F.R., Cadet J.L. Differential effects of cocaine and cocaine + alcohol on neurocognitive performance. Neurology 2000, 5:2285-2292.
48. Di Sclafani V., Tolou-Shams M., Price L.J., Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002, 66:161-171.
49. Shearer J. Psychosocial approaches to psychostimulant dependence: A systematic review. J Subst Abuse Treat 2007, 32:41-52.
50. Simpson D.D., Joe G.W., Broome K.M. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 2002, 59:538-544.
51. Couzigou P., Vergniol J., Kowo M., Terrebonne E., Foucher J., Castera L., et al. Intervention brève en alcoologie. Presse Med 2009, 38:1126-1133.
52. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994, 51:989-997.
53. Carroll K.M., Rounsaville B.J., Keller D.S. Relapse prevention strategies in the treatment of cocaine abuse. Am J Drug Alcohol Abuse 1991, 17:249-265.
54. Rash C.J., Alessi S.M., Petry N.M. Cocaine abusers with and without alcohol dependence respond equally well to contingency management treatments. Exp Clin Psychopharmacol 2008, 16:275-281.
55. Higgins S.T., Sigmon S.C., Wong C.J., Heil S.H., Badger G.J., Donham R., et al. Community Reinforcement Therapy for Cocaine-Dependent Outpatients. Arch Gen Psychiatry 2003, 60:1043-1052.
56. Schiffer F. Psychotherapy of nine successfully treated cocaine abusers: techniques and dynamics. J Subst Abuse Treat 1998, 5(1):31-37.
57. Prescrire Rédaction. Le syndrome de sevrage alcoolique. Le prévoir, le prévenir, le repérer et le traiter. Rev Prescrire 2006; 26:592-301.
58. Castaneda R., Lifshutz H., Westreich L., Galanter M. Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. Compr Psychiatry 1995, 36:441-447.
59. Kampman K.M., Pettinati H., Volpicelli J., Kaempf G., Turk E., Insua A., et al. Concurrent cocaine withdrawal alters alcohol withdrawal symptoms. J Addict Dis 2002, 21:13-26.
60. Kosten T.R., O'Connor P.G. Management of Drug and Alcohol Withdrawal. N Engl J Med 2003, 348:1786-1795.
61. Carroll K.M., Nich C., Ball S.A., McCance E., Frankforter T.L., Rounsaville B.J. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction 2000, 95:1335-1349.
62. Carroll K.M., Nich C., Ball S.A., McCance E., Rounsaville B.J. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998, 93:713-728.
63. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 2004, 61:264-272.
64. Malcolm R., Olive M.F., Lechner W. The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf 2008, 7:459-472.
65. Gossop M., Carroll K.M. Disulfiram, cocaine, and alcohol: two outcomes for the price of one?. Alcohol Alcohol 2006, 41:119-120.
66. Oslin D.W., Pettinati H.M., Volpicelli J.R., Wolf A.L., Kampman K.M., O'Brien C.P. The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat 1999, 16:163-167.
67. Hersh D., van Kirk J.R., Kranzler H.R. Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology (Berl) 1998, 139:44-52.
68. Schmitz J.M., Stotts A.L., Sayre S.L., DeLaune K.A., Grabowski J. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. Am J Addict 2004, 13:333-341.
69. Carroll K., Ziedonis D., O'Malley S., McCance-Katz E., Gordon L., Rounsaville B. Pharmacologic interventions for alcohol- and cocaine-abusing individuals: a pilot study of disulfiram vs. Naltrexone. Am J Addict 1993, 2:77-79.
70. Grassi M.C., Cioce A.M., Dei Giudici F., Antonilli L., Nencini P. Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: A pilot study. Pharmacol Research 2007, 55:117-121.
71. Pettinati H.M., Kampman K.M., Lynch K.G., Suh J.J., Dackis C.A., Oslin D.W., et al. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat 2008, 34:378-390.
72. Petrakis I.L., Poling J., Levinson C., Nich C., Carroll K., Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 2005, 57:1128-1137. VA New England VISN I MIRECC Study Group.
73. Pettinati H.M., Kampman K.M., Lynch K.G., Xie H., Dackis C., Rabinowitz A.R., et al. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav 2008, 33:651-667.
74. Karila L., Weinstein A., Benyamina A., Coscas S., Leroy C., Noble F., et al. Pharmacothérapies actuelles et immunothérapie dans l'addiction à la cocaïne. Presse Med 2008, 37:689-698.
75. Johnson B.A. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate Function. CNS Drugs 2005, 19:873-896.
76. Kenna G.A., Nielsen D.M., Mello P., Schiesl A., Swift R.M. Pharmacotherapy of dual substance abuse and dependence. CNS Drugs 2007, 21:213-237.
77. Anton R.F., Kranzler H., Breder C., Marcus R.N., Carson W.H., Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol 2008, 28:5-12.
78. Bergman J. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Exp Clin Psychopharmacol 2008, 16:475-483.
79. Vorspan F., Bellais L., Keijzer L., Lépine J.P. An open-label study of aripiprazole in nonschizophrenic crack-dependent patients. J Clin Psychopharmacol 2008, 28:570-572.
80. Johnson B.A., Roache J.D., Ait-Daoud N., Javors M.A., Harrison J.M., Elkashef A., et al. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence. Drug Alcohol Depend 2006, 84:256-263.